Statutes, codes, and regulations
District of Columbia Official Code
Division I - GOVERNMENT OF DISTRICTTitle 7 - HUMAN HEALTH CARE AND SAFETYSubtitle J - PUBLIC SAFETYChapter 23D - PUBLIC ACCESS TO DEFIBRILLATORS AND EPINEPHRINE.
Subchapter II - ACCESS TO TREATMENT FOR ANAPHYLAXIS
Section 7-2381.03 - Authorized use

D.C. Code § 7-2381.03

Download
PDF
Current through codified legislation effective September 18, 2024
Section 7-2381.03 - Authorized use

An employee or agent of an authorized entity who has completed the training program described in § 7-2381.04 may use an epinephrine auto-injector prescribed pursuant to § 7-2381.02 to:

(1) Provide an epinephrine auto-injector to any individual who the employee or agent believes in good faith is experiencing anaphylaxis, for immediate administration;
(2) Provide an epinephrine auto-injector to the parent, guardian, or caregiver of an individual who the employee or agent believes in good faith is experiencing anaphylaxis, for immediate administration; or
(3) Administer an epinephrine auto-injector to any individual who the employee or agent believes in good faith is experiencing anaphylaxis.

D.C. Code § 7-2381.03

Feb. 22, 2019, D.C. Law 22-207, § 4, 65 DCR 12365.

Applicability

Applicability of D.C. Law 22-207: § 7155 of D.C. Law 23-16 repealed § 10 of D.C. Law 22-207. Therefore the creation of this section by D.C. Law 22-207 has been implemented.

Applicability of D.C. Law 22-207: § 10 of D.C. Law 22-207 provided that the creation of this section by § 4 of D.C. Law 22-207 is subject to the inclusion of the law's fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.